Omalu helped develop and is invested in the diagnostic exam, which uses a radioactive “tracer” called FDDNP to bind to tau proteins in the brain. The tau proteins can then be seen on a PET scan of the brain.  {read more here}

Using PET with the radiotracer 18F-florbetapir, researchers in Sweden have found that the topology of amyloid clusters can help tip off clinicians to the presence and progression of Alzheimer’s disease in patients who don’t yet present symptoms. {read more here}

From the total study sample, 104 participated in a two-year longitudinal study that found a correlation between the severity of OSA and an increase in amyloid deposits in the brain. That finding was confirmed in the subset of participants who underwent amyloid PET [imaging], which showed an increase in amyloid burden in those with OSA, according to the researchers. {read more here}

German scientists have developed a novel nuclear medicine test that can determine whether a kidney transplant patient has developed infection in the transplanted tissue. The study, which utilizes positron emission tomography/magnetic resonance imaging (PET/MRI), is presented in the November issue of The Journal of Nuclear Medicine.  {read more here}